Search

Your search keyword '"Singer, Eric A."' showing total 1,136 results

Search Constraints

Start Over You searched for: Author "Singer, Eric A." Remove constraint Author: "Singer, Eric A."
1,136 results on '"Singer, Eric A."'

Search Results

4. Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

6. Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial

9. Informed consent and trainee participation in urologic surgery

13. PHIP drives glioblastoma motility and invasion by regulating the focal adhesion complex

15. Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative

17. PD23-08 RETHINKING THE DEFINITION OF STAGE III IN ADRENOCORTICAL CARCINOMA: ASSESSING THE IMPACT OF CLINICAL LYMPH NODE POSITIVE DISEASE

18. Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability

19. Adversarial Domain Adaptation for Classification of Prostate Histopathology Whole-Slide Images

20. Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer.

22. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

26. Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor Genomics.

30. Supplementary Table 3 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

31. FIGURE 2 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

32. Supplementary Table 5 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

33. Supplementary Table 1 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

34. Supplementary Figure 1 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

35. FIGURE 1 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

36. Supplementary Table 6 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

37. Supplementary Table 4 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

38. Supplementary Table 2 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

39. Data from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

40. FIGURE 3 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

41. Supplementary Table 7 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

43. A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset

44. Sex-based differences in the transcriptomic metabolic profiling in young onset colorectal cancer (YOCRC).

45. Comparing the rate of immunotherapy treatment change due to toxicity by sex

47. Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer

49. Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study

Catalog

Books, media, physical & digital resources